Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAN 2022 | Mechanisms and triggers of autoimmune neurological conditions

Divyanshu Dubey, MBBS, Mayo Clinic, Rochester, MN, discusses the pathophysiological basis of autoimmune diseases of the nervous system and factors that may trigger their development. Immune-mediated disorders can be categorized into autoimmune disorders and autoinflammatory disorders. Autoimmune disorders can be antibody-mediated conditions, such as neurofascin-155 or T-cell-mediated conditions. Regarding the factors that may trigger their development, the most known triggers are underlying cancer and infections. However, some patients present with idiopathic forms where the exact cause is unknown. This interview took place at the American Academy of Neurology 2022 Congress in Seattle, WA.

Disclosures

Dr Dubey has consulted for UCB, Immunovant and Astellas Pharmaceuticals. All compensation for consulting activities is paid directly to Mayo Clinic. Dr Dubey has patents pending for Kelch-like protein 11 (KLHL11) IgG and Leucine Zipper 4 (LUZP4) IgG as markers of neurological autoimmunity.

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.